Serum alpha-fetoprotein measurement in predicting clinical outcome related to autologous cytokine-induced killer cells in patients with hepatocellular carcinoma undergone minimally invasive therapy
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.